Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Overview of Regeneration and Repair01:19

Overview of Regeneration and Repair

4.8K
Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
4.8K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Healing I: Introduction01:11

Healing I: Introduction

15
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated aortic valve-sparing aortic root replacement in elective patients with bicuspid aortic valve: A single-center experience.

JTCVS open·2026
Same author

Comparison of the Self-Expandable Intra-Annular Navitor Prosthesis with the Balloon-Expandable, Intra-Annular Sapien 3 Prosthesis: A Propensity-Matched Analysis.

Journal of clinical medicine·2026
Same author

Long-Term Outcomes after Redo Coronary Artery Bypass Grafting: A Propensity-Matched Analysis of On-Pump and Off-Pump Techniques.

The Thoracic and cardiovascular surgeon·2026
Same author

Long-term results of mitral valve repair using leaflet resection versus chordae replacement.

JTCVS techniques·2026
Same author

It happened tomorrow-transcatheter treatments in the lifetime management of aortic valve diseases.

Journal of visualized surgery·2026
Same author

Surgery for Failing Transcatheter Tricuspid Heart Valves.

JACC. Case reports·2026

Related Experiment Video

Updated: May 5, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.9K

Cardiac regeneration: current therapies-future concepts.

Stefanie A Doppler1, Marcus-André Deutsch, Rüdiger Lange

  • 1Department of Experimental Surgery, Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München (TUM), Munich Heart Alliance, Munich, Germany.

Journal of Thoracic Disease
|November 21, 2013
PubMed
Summary

Cardiovascular disease treatments face challenges. Stem cell therapies show promise for heart repair but yield inconsistent functional improvements, necessitating new regenerative strategies.

Keywords:
Myocardial infarctionregenerative medicinereprogrammingstem cellstissue engineering

More Related Videos

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

54.6K
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

19.1K

Related Experiment Videos

Last Updated: May 5, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.9K
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
07:41

Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction

Published on: June 7, 2011

54.6K
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

19.1K

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality and imposes a significant healthcare burden.
  • Current therapeutic strategies for CVD are limited, driving the need for novel approaches.
  • Stem cell-based therapies have emerged as a potential strategy for myocardial regeneration and repair.

Purpose of the Study:

  • To review current evidence on stem cell-based regenerative therapies for cardiovascular disease.
  • To discuss the limitations and inconsistent outcomes of existing stem cell approaches.
  • To explore future strategies for improving functional recovery in myocardial regeneration.

Main Methods:

  • Review of current clinical trials and scientific literature on stem cell therapies for CVD.
  • Analysis of outcomes from studies using various adult stem cell populations (bone marrow, adipose, cardiac).
  • Discussion of emerging concepts in myocardial regeneration, including cell transplantation, reprogramming, tissue engineering, and pharmacological stimulation.

Main Results:

  • Stem cell therapies (e.g., bone marrow-derived stem cells) have demonstrated safety and feasibility in clinical trials for CVD.
  • Functional improvements following stem cell transplantation for myocardial repair have been generally low and inconsistent.
  • Existing studies highlight the need for improved strategies to achieve significant cardiomyocyte regeneration and functional recovery.

Conclusions:

  • While stem cell therapies offer potential for cardiovascular repair, current approaches have not met expectations for functional improvement.
  • Future research must focus on developing novel regenerative strategies, such as utilizing progenitor cells with true regenerative capacity, direct scar reprogramming, tissue engineering, or pharmacological stimulation of endogenous repair.
  • Advancing myocardial regeneration requires innovative concepts to address cardiomyocyte loss and enhance functional outcomes in cardiovascular disease patients.